Sg Americas Securities, LLC X4 Pharmaceuticals, Inc Transaction History

Sg Americas Securities, LLC

  • $17.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$0.72 - $1.46 $19,329 - $39,195
-26,846 Reduced 56.32%
20,822 $29,000
Q4 2023

Jan 12, 2024
BUY
$0.61 - $0.99 $8,130 - $13,194
13,328 Added 38.81%
47,668 $40,000
Q3 2023

Oct 13, 2023
BUY
$1.03 - $2.02 $35,370 - $69,366
34,340 New
34,340 $37,000

Others Institutions Holding XFOR

# of Institutions
107
Shares Held
101M
Call Options Held
418K
Put Options Held
71.7K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $45.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email